Schott Pharma Shares Surge 11% After Deutsche Bank Upgrades to Buy – Market & Analyst Outlook 2026
Schott Pharma’s stock soars after Deutsche Bank lifts target to €22, citing stronger ops in H2 and growing injection‑system demand.
2 minutes to read
SCHOTT PHARMA AG& CO KGAA